Genzyme 2004 Annual Report - Home About Genzyme Site Map Legal Disclaimer
Genzyme 2004 Annual Report
Genzyme Logo
Table of Contents
2004 - A Transforming Year
Financial Highlights
Letter To Shareholders
A Future of Hope
Building a Sustainable Future
Focused Medical Areas
Genetic Diseases
Renal Disease
Strong Foundation For Growth
A First-Line Therapy
Expanding Access
Broadening Renal Care
Orthopaedics
Oncology
Transplant / Immune Diseases
Genetics / Diagnostics
A Future of Innovation
A Future of Commitment
A Future of Growth
Renal Disease
Renagel is growing significantly around the world based on its strong foundation in the United States, Europe, and Japan. With more than 1.2 million people around the globe undergoing kidney dialysis, the need and the prospects are both substantial.

PhotoRenegel Patient
Nametag

Shad has fulfilled his goal of becoming the first person on dialysis ever to compete in and complete an Ironman triathlon. He is sustained by his belief that living with a chronic illness is “not a limitation, but a special invitation to those of us who are willing to accept the challenge.”